This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.
singleton pregnancy
no prior diagnosis of diabetes (gestational included)
scheduled term cesarean delivery in Mount Sinai Health System
aged 18-50 years
preexisting diabetes mellitus
diagnosis of gestational diabetes mellitus (GDM) in the current pregnancy, based on standard prenatal screening
known endocrine disorder affecting glucose metabolism (such as Cushing syndrome, poorly controlled thyroid disorder, etc.)
use of antenatal steroids within the two weeks prior to delivery
continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients
Cohort
Prospective
Continuous Glucose Monitor
DeviceContinuous glucose monitor during perioperative Cesarean delivery
interstitial glucose from CGM device
glucose of interstitial fluid as measured by CGM device on participant's arm
Number of surgical site infection
Diagnosis of surgical site infection as a measure of post-operative complications
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
